2001
DOI: 10.1128/iai.69.12.7481-7486.2001
|View full text |Cite
|
Sign up to set email alerts
|

Nasal and Vaginal Vaccinations Have Differential Effects on Antibody Responses in Vaginal and Cervical Secretions in Humans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
108
0
4

Year Published

2002
2002
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 160 publications
(115 citation statements)
references
References 31 publications
3
108
0
4
Order By: Relevance
“…Although IgA plasma cells generated in small intestine and colon preferentially home into small intestine and colon, respectively (32), those generated by immunization via nasal cavity preferentially home into nasopharyngeal and respiratory mucosal tissues, but not into intestinal tissues (33,34). Such differential migratory properties of IgA plasma cells in accordance with their tissue origin are likely to be explained in part by their expression of a different set of chemokine receptors (5).…”
Section: Discussionmentioning
confidence: 99%
“…Although IgA plasma cells generated in small intestine and colon preferentially home into small intestine and colon, respectively (32), those generated by immunization via nasal cavity preferentially home into nasopharyngeal and respiratory mucosal tissues, but not into intestinal tissues (33,34). Such differential migratory properties of IgA plasma cells in accordance with their tissue origin are likely to be explained in part by their expression of a different set of chemokine receptors (5).…”
Section: Discussionmentioning
confidence: 99%
“…However, it was noted that women in the V imm group developed local Ab responses that differed tremendously in magnitude (8), possibly because vaccine was administered at alternating follicular and luteal phases of the menstrual cycle. It has been reported that biweekly V imm of women on days 10 and 24 of the menstrual cycle is better than random biweekly V imm for induction of specific IgA Ab in cervical secretions (9). However, comparative studies addressing the outcome of V imm in relation to the specific menstrual cycle phases during which Ag is administered have not been performed in humans.…”
mentioning
confidence: 99%
“…However, those immunized vaginally on days 10 and 24 of their menstrual cycle had the greatest amounts of IgG and IgA in cervical secretions, compared to those immunized vaginally irrespective of cycle stage. 115 With these factors in mind, any vaccine targeted to the female reproductive tract must induce a strong CMI and humoral response that is able to overcome the effects of hormonal fluctuations.…”
Section: Problems With Vaccine Developmentmentioning
confidence: 99%